Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? DEFICIT

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
AOCI Attributable to Parent
Beginning balance (in shares) at Dec. 31, 2020 43,836,109          
Beginning balance at Dec. 31, 2020 $ 151,938          
Ending Balance (in shares) at Jun. 30, 2021 43,836,109          
Ending balance at Jun. 30, 2021 $ 151,938          
Beginning balance at Dec. 31, 2020 (113,945)   $ 0 $ 16,261 $ (130,208) $ 2
Common stock, beginning balance (in shares) at Dec. 31, 2020     11,882,286      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares)     2,172,731      
Issuance of common shares from stock option exercises 2,125     2,125    
Stock-based compensation 7,093     7,093    
Change in foreign currency translation, net of tax (8)         (8)
Net loss (23,402)       (23,402)  
Ending balance at Jun. 30, 2021 $ (128,137)   $ 0 25,479 (153,610) (6)
Common stock, ending balance (in shares) at Jun. 30, 2021     14,055,017      
Beginning balance (in shares) at Mar. 31, 2021 43,836,109          
Beginning balance at Mar. 31, 2021 $ 151,938          
Ending Balance (in shares) at Jun. 30, 2021 43,836,109          
Ending balance at Jun. 30, 2021 $ 151,938          
Beginning balance at Mar. 31, 2021 (120,857)   $ 0 18,333 (139,191) 1
Common stock, beginning balance (in shares) at Mar. 31, 2021     12,829,591      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares)     1,225,426      
Issuance of common shares from stock option exercises 1,877     1,877    
Stock-based compensation 5,269     5,269    
Change in foreign currency translation, net of tax (7)         (7)
Net loss (14,419)       (14,419)  
Ending balance at Jun. 30, 2021 $ (128,137)   $ 0 25,479 (153,610) (6)
Common stock, ending balance (in shares) at Jun. 30, 2021     14,055,017      
Beginning balance (in shares) at Dec. 31, 2021 0          
Beginning balance at Dec. 31, 2021 $ 0          
Preferred stock, beginning balance (in shares) at Dec. 31, 2021 0          
Beginning balance at Dec. 31, 2021 $ 112,301   $ 0 294,230 (181,898) (31)
Common stock, beginning balance (in shares) at Dec. 31, 2021 64,324,628   64,324,628      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares) 564,083          
Preferred stock, ending balance (in shares) at Mar. 31, 2022   0        
Ending balance at Mar. 31, 2022 $ 102,501 $ 0 $ 0 298,214 (195,736) 23
Common stock, ending balance (in shares) at Mar. 31, 2022     64,889,304      
Beginning balance (in shares) at Dec. 31, 2021 0          
Beginning balance at Dec. 31, 2021 $ 0          
Ending Balance (in shares) at Jun. 30, 2022 0          
Ending balance at Jun. 30, 2022 $ 0          
Preferred stock, beginning balance (in shares) at Dec. 31, 2021 0          
Beginning balance at Dec. 31, 2021 $ 112,301   $ 0 294,230 (181,898) (31)
Common stock, beginning balance (in shares) at Dec. 31, 2021 64,324,628   64,324,628      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares)     685,324      
Issuance of common shares from stock option exercises $ 693     693    
Offering costs (271)     (271)    
Vesting of restricted stock units (in shares)     767      
Stock-based compensation 7,905     7,905    
Change in foreign currency translation, net of tax 13         13
Net loss $ (28,653)       (28,653)  
Preferred stock, ending balance (in shares) at Jun. 30, 2022 0 0        
Ending balance at Jun. 30, 2022 $ 91,988 $ 0 $ 0 302,557 (210,551) (18)
Common stock, ending balance (in shares) at Jun. 30, 2022 65,010,719   65,010,719      
Ending Balance (in shares) at Jun. 30, 2022 0          
Ending balance at Jun. 30, 2022 $ 0          
Preferred stock, beginning balance (in shares) at Mar. 31, 2022   0        
Beginning balance at Mar. 31, 2022 $ 102,501 $ 0 $ 0 298,214 (195,736) 23
Common stock, beginning balance (in shares) at Mar. 31, 2022     64,889,304      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares from stock option exercises (in shares) 121,241   121,241      
Issuance of common shares from stock option exercises $ 134     134    
Offering costs (271)     (271)    
Vesting of restricted stock units (in shares)     174      
Stock-based compensation 4,480     4,480    
Change in foreign currency translation, net of tax (41)         (41)
Net loss $ (14,815)       (14,815)  
Preferred stock, ending balance (in shares) at Jun. 30, 2022 0 0        
Ending balance at Jun. 30, 2022 $ 91,988 $ 0 $ 0 $ 302,557 $ (210,551) $ (18)
Common stock, ending balance (in shares) at Jun. 30, 2022 65,010,719   65,010,719